Jeremy Yuen-Chun Teoh1, Chi-Fai Ng2, Masatoshi Eto3, Mallikarjuna Chiruvella4, Umberto Capitanio5, Tarik Esen6, Guohua Zeng7, Eric Lechevallier8, Sero Andonian9, Jean de la Rosette10. 1. S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China. jeremyteoh@surgery.cuhk.edu.hk. 2. S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China. 3. Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. 4. Department of Urology, Asian Institute of Nephrology and Urology, Hyderabad, Telangana, India. 5. Unit of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy. 6. Department of Urology, Koc University Hospital, Istanbul, Turkey. 7. Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. 8. Department of Urology and Kidney Transplantation, Conception Academic Hospital, Aix-Marseille University, APHM, Marseille, France. 9. Division of Urology, McGill University, Montreal, QC, Canada. 10. Department of Urology, Medipol Mega University Hospital, Istanbul Medipol University, Istanbul, Turkey.
Abstract
PURPOSE: We investigated the effects of age, American Society of Anesthesiologists Physical Status Classification (ASA) grading and Charlson Comorbidity Index (CCI) on the survival outcomes of upper tract urothelial carcinoma (UTUC). METHODS: The CROES-UTUC registry was an international, multicenter study on patients with UTUC. Primary outcomes were overall survival (OS) and disease-free survival (DFS). Kaplan-Meier and multivariate Cox regression analyses were performed by stratifying patients according to their age (≤ 70 and > 70 years old) and ASA grade (I-II and III-V)/CCI (0-1 and ≥ 2). RESULTS: A total of 2352 patients were included in this study. Patients aged ≤ 70 years with ASA grading of I-II (p = 0.002), and patients aged ≤ 70 years with a CCI of 0-1 (p = 0.002) had the best OS. Upon multivariate analysis, both in patients aged ≤ 70 and > 70 years, ASA grading and CCI were not significantly associated with OS. Patients aged ≤ 70 years with ASA grading of III-IV (p = 0.024) had the best DFS. When stratified according to age and CCI, no significant difference in DFS was noted. Upon multivariate analysis, radical nephroureterectomy (RNU) was significantly associated with better DFS in patients aged ≤ 70 and > 70 years; CCI of ≥ 3 was significantly associated with worse DFS in patients ≤ 70 years; ASA grading was not associated with DFS in patients aged ≤ 70 and > 70 years. CONCLUSIONS: A high ASA grading and CCI should not be considered contraindications for RNU. RNU should be considered even in elderly patients when it is deemed feasible and achievable after a geriatric assessment.
PURPOSE: We investigated the effects of age, American Society of Anesthesiologists Physical Status Classification (ASA) grading and Charlson Comorbidity Index (CCI) on the survival outcomes of upper tract urothelial carcinoma (UTUC). METHODS: The CROES-UTUC registry was an international, multicenter study on patients with UTUC. Primary outcomes were overall survival (OS) and disease-free survival (DFS). Kaplan-Meier and multivariate Cox regression analyses were performed by stratifying patients according to their age (≤ 70 and > 70 years old) and ASA grade (I-II and III-V)/CCI (0-1 and ≥ 2). RESULTS: A total of 2352 patients were included in this study. Patients aged ≤ 70 years with ASA grading of I-II (p = 0.002), and patients aged ≤ 70 years with a CCI of 0-1 (p = 0.002) had the best OS. Upon multivariate analysis, both in patients aged ≤ 70 and > 70 years, ASA grading and CCI were not significantly associated with OS. Patients aged ≤ 70 years with ASA grading of III-IV (p = 0.024) had the best DFS. When stratified according to age and CCI, no significant difference in DFS was noted. Upon multivariate analysis, radical nephroureterectomy (RNU) was significantly associated with better DFS in patients aged ≤ 70 and > 70 years; CCI of ≥ 3 was significantly associated with worse DFS in patients ≤ 70 years; ASA grading was not associated with DFS in patients aged ≤ 70 and > 70 years. CONCLUSIONS: A high ASA grading and CCI should not be considered contraindications for RNU. RNU should be considered even in elderly patients when it is deemed feasible and achievable after a geriatric assessment.
Authors: Morgan Rouprêt; Marko Babjuk; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Nigel C Cowan; Jose L Dominguez-Escrig; Paolo Gontero; A Hugh Mostafid; Joan Palou; Benoit Peyronnet; Thomas Seisen; Viktor Soukup; Richard J Sylvester; Bas W G van Rhijn; Richard Zigeuner; Shahrokh F Shariat Journal: Eur Urol Date: 2020-06-24 Impact factor: 20.096
Authors: Thomas F Chromecki; Behfar Ehdaie; Giacomo Novara; Karl Pummer; Richard Zigeuner; Christian Seitz; Armin Pycha; Richard K Lee; Eugene K Cha; Pierre I Karakiewicz; Casey Ng; Jay D Raman; Felix K Chun; Hans-Martin Fritsche; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Patrick J Bastian; Juan I Martínez-Salamanca; Douglas S Scherr; Shahrokh F Shariat Journal: World J Urol Date: 2011-04-17 Impact factor: 4.226
Authors: Marco Moschini; Beat Foerster; Mohammad Abufaraj; Francesco Soria; Thomas Seisen; Morgan Roupret; Pierre Colin; Alexandre De la Taille; Benoit Peyronnet; Karim Bensalah; Roman Herout; Manfred Peter Wirth; Vladimir Novotny; Piotr Chlosta; Marco Bandini; Francesco Montorsi; Giuseppe Simone; Michele Gallucci; Giuseppe Romeo; Kazumasa Matsumoto; Pierre Karakiewicz; Alberto Briganti; Shahrokh F Shariat Journal: World J Urol Date: 2017-02-28 Impact factor: 4.226
Authors: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Ahmed Alasker; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: Eur J Cancer Date: 2009-07-15 Impact factor: 9.162
Authors: Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann Journal: World J Urol Date: 2016-09-07 Impact factor: 4.226
Authors: Morgan Rouprêt; Vincent Hupertan; Thomas Seisen; Pierre Colin; Evanguelos Xylinas; David R Yates; Harun Fajkovic; Yair Lotan; Jay D Raman; Richard Zigeuner; Mesut Remzi; Christian Bolenz; Giacomo Novara; Wassim Kassouf; Adil Ouzzane; François Rozet; Olivier Cussenot; Juan I Martinez-Salamanca; Hans-Martin Fritsche; Thomas J Walton; Christopher G Wood; Karim Bensalah; Pierre I Karakiewicz; Francesco Montorsi; Vitaly Margulis; Shahrokh F Shariat Journal: J Urol Date: 2012-10-24 Impact factor: 7.450
Authors: Shahrokh F Shariat; Guilherme Godoy; Yair Lotan; Michael Droller; Pierre I Karakiewicz; Jay D Raman; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Jeffrey C Wheat; Richard Zigeuner; Cord Langner; Christopher G Wood; Vitaly Margulis Journal: BJU Int Date: 2009-11-13 Impact factor: 5.588
Authors: Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Weizer; Jay D Raman; Christopher G Wood Journal: Cancer Date: 2009-03-15 Impact factor: 6.860
Authors: Joyce Baard; Merve Celebi; Jean de la Rosette; Antonio Alcaraz; Shahrokh Shariat; Luigi Cormio; Vítor Cavadas; M Pilar Laguna Journal: JMIR Res Protoc Date: 2020-01-24